A group of Alzheimer’s experts and health advocates called on the F.D.A. to withdraw its approval of the drug, the latest of several setbacks for the treatment.
Posted inBusiness
Biogen Slashes Price of Alzheimer’s Drug Aduhelm, as It Faces Obstacles
